Elvin Wagenblast
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 2
- Oncology top 10%
-
- Epigenetics and DNA Methylation 5
- Pluripotent Stem Cells Research 2
- RNA Interference and Gene Delivery 2
- Hematology top 10%
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 3
-
- Acute Lymphoblastic Leukemia research 3
- Co-authors
- Gregory J. HannonSimon KnottSun Y. KimNicolas ErardAndrew D. SmithCarol PrivesEusebio ManchadoThomas Kitzing
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Elvin Wagenblast
18 papers receiving 913 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 301
- Oncology 434
- Molecular Biology 589
- Hematology 83
- Biotechnology 47
Countries citing papers authored by Elvin Wagenblast
This map shows the geographic impact of Elvin Wagenblast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elvin Wagenblast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elvin Wagenblast more than expected).
Fields of papers citing papers by Elvin Wagenblast
This network shows the impact of papers produced by Elvin Wagenblast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elvin Wagenblast. The network helps show where Elvin Wagenblast may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elvin Wagenblast, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 16 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 1 | |
| 9 | 2020 | 18 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 23 | |
| 13 | 2019 | 1 | |
| 14 | 2018 | 16 | |
| 15 | 2018 | 74 | |
| 16 | 2018 | 1 | |
| 17 | 2018 | 1 | |
| 18 | 2015 | 310 | |
| 19 | 2014 | 69 | |
| 20 | Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signalingbreakdown → | 2014 | 362 |
About Elvin Wagenblast
Elvin Wagenblast is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 21 papers that have together received 923 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Epigenetics and DNA Methylation (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer Genomics and Diagnostics (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Pluripotent Stem Cells Research (2 papers), RNA Interference and Gene Delivery (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (301 citations), Oncology (434 citations) and Molecular Biology (589 citations). Elvin Wagenblast has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Gregory J. Hannon, Simon Knott, Sun Y. Kim, Nicolas Erard, Andrew D. Smith, Carol Prives, Eusebio Manchado, Thomas Kitzing, Sean M. Grimmond and Sung‐Hwan Moon. Their work appears in journals such as Nature, Cell and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.